Year: 2019

Belships ASA (OSE: BEL) has released an updated company presentation following the Report 3rd quarter 2019.For further information, please contact Lars Christian Skarsgård, Belships CEO, phone +47 977 68 061 or e-mail LCS@belships.noAttachmentCompany_presentation_Q319

CONTINUED PROFITABILITY AND GROWTHHIGHLIGHTSOperating income of USD 31.7 million (Q3 2018: USD 27.1m)EBITDA of USD 8.1m (Q3 2018: USD 6.4m)Net result of USD 0.3m (Q3 2018: USD 4.4m) impacted by one-off costsNet TCE (Time charter equivalent) per ship of USD 11,118 per day versus net BSI index of USD 11,886 per dayAbout 65% of ship days in Q4 have been booked at about USD 12,625 net per dayAverage cash breakeven per vessel about USD 9,000 per day for next 12 monthsReported EBITDA includes operating expenses of USD 1.3m arising from the service element embedded in long-term time charter lease agreements classified as financial leasesIncreased 2020 bunkers hedge from 24,000mt to 36,000mtThree bareboat charter agreements with purchase options concluded in the quarterOne bareboat charter agreement with purchase options concluded in OctoberAgreed...

THIRD QUARTER In Q3 2019, Lerøy Seafood Group (LSG) reported revenue of NOK 5,102 million, compared with NOK 4,456 million in the same period in 2018. Operating profit before fair value adjustment related to biological assets was NOK 501 million in Q3 2019, compared with NOK 660 million in Q3 2018. Downstream operations have reported positive growth in earnings when compared with the same period in 2018. However, lower earnings for Farming, attributed to lower prices realised and higher release from stock costs, represent the most significant reason behind the fall in earnings in Q3 2019 when compared with Q3 2018.Exclusive of earnings from the Wild Catch segment, this corresponds to an EBIT per kilo before value adjustment related to biological asset in Q3 2019 of NOK 9.8 compared to NOK 16.6 for the same period in 2018.The Group reports...

TREDJE KVARTAL   Lerøy Seafood Group (LSG) oppnådde en omsetning på MNOK 5.102 i tredje kvartal 2019, sammenlignet med MNOK 4.456 i samme periode i 2018. Driftsresultat før verdijusteringer knyttet til biologiske eiendeler ble MNOK 501 i tredje kvartal 2019, sammenlignet med MNOK 660 i tredje kvartal 2018. Nedstrømsaktivitetene har god vekst i inntjeningen sett i forhold til  samme periode i 2018, men  lavere inntjening i Havbruk, drevet av lavere prisoppnåelse og høyere uttakskostnader, er den viktigste årsaken til lavere inntjening i tredje kvartal 2019 sammenlignet med samme periode i fjor.Ekskludert inntjening fra Villfangst, gir dette et driftsresultat per kilo før biomassejustering på NOK 9,8 mot NOK 16,6 i samme periode i fjor.Per tredje kvartal rapporterer konsernet en omsetning på MNOK 15.188, sammenlignet med MNOK 14.498 i tilsvarende...

DUEREN, Germany, Nov. 14, 2019 (GLOBE NEWSWIRE) — GBLT Corp. (the “Company”) (TSXV:GBLT) (OTCQB:GBLTF), at the request of the Market Surveillance group of the Investment Industry Regulatory Organization of Canada (IIROC), announces that the Company is not aware of any material undisclosed information that may be contributing to the level of trading activity of its shares on the TSX Venture Exchange.In addition, the Company wishes to make the following statements regarding recent market activity in its common stock traded on the OTCQB marketplace.The Company became aware of certain promotional activities related to its securities on November 13, 2019 upon receipt of correspondence from OTC Markets specifically related to certain promotional newsletter emails encouraging investors to purchase the Company’s common stock. Until...

BELTSVILLE, Md., Nov. 14, 2019 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the pricing of its public offering of 4,077,192 shares of its common stock at a public offering price of $36.75 per share. NextCure also granted the underwriters a 30-day option to purchase up to an additional 611,578 shares of its common stock at the public offering price less the underwriting discounts and commissions. All of the common stock to be sold in the offering are being offered by NextCure. Gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $150 million, excluding...

SANTA CLARA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (“Shockwave”) (Nasdaq: SWAV) today announced the pricing of its public offering of 2,481,781 shares of its common stock at a price to the public of $36.25 per share. All of the shares are being offered by Shockwave. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Shockwave, are expected to be approximately $90.0 million. The offering is scheduled to close on November 19, 2019, subject to the satisfaction of customary closing conditions. The underwriters for the offering also have a 30-day option to purchase up to an additional 372,267 shares of Shockwave’s common stock at the price to the public, less underwriting discounts and commissions. Shockwave’s common stock is...

TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) — Amarillo Gold Corp. (“Amarillo” or the “Company”) (TSXV: AGC) (OTCQB:AGCBF), is pleased to announce that it has entered into debt settlement agreements with certain creditors of the Company, including two directors of the Company. Pursuant to these agreements, the Company has agreed to issue an aggregate of 1,098,798 common shares (“Common Shares”) in the capital of the Company at a deemed price of $0.21 per Common Share to settle $230,748 of outstanding debt (collectively, the “Shares for Debt Transactions”).  The completion of the Shares for Debt Transactions is subject to a number of conditions, including the approval of the TSX Venture Exchange (the “TSXV”). All securities issued pursuant to the Shares for Debt Transactions will be subject to a hold period of four months and one day...

WASHINGTON and RESTON, Va., Nov. 14, 2019 (GLOBE NEWSWIRE) — On November 14, 2019, Comstock Holding Companies, Inc., (NASDAQ: CHCI) (the “Company”), announced results for the three and nine months ended September 30, 2019:Highlights from continuing operations of Third Quarter 2019, as compared to Third Quarter 2018:Total revenue of $5.2 million, an increase of 52% as compared to $3.4 million during the same period of the prior year.Asset management revenues of $4.3 million, an increase of 57% compared to $2.7 million during the same period of the prior year.Revenue from real estate services of $0.9 million, an increase of 33% compared to $0.7 million during the same period of the prior year.Operating income of $0.3 million as compared to ($0.1 million) during the same period of the prior year before accounting for non-cash charges...

EDMONTON, Alberta, Nov. 14, 2019 (GLOBE NEWSWIRE) — Alcanna Inc. (the “Company” or “Alcanna”) (TSX: CLIQ) today reported its results for the three and nine months ended September 30, 2019.The Company achieved 26.6% growth in total sales compared to the third quarter of 2018 and same-store sales growth of 4.9% in its core Canadian liquor retail business. This marks the fourth straight quarter of strong market share gains by Alcanna. “We continue to execute our strategy according to plan in the third quarter. Regaining and growing market share in our core Alberta liquor business and beginning to carefully raise margins as we said we would,” said James Burns CEO. “Margin enhancements are continuing in the fourth quarter and we are on track for enhanced profitability in 2020 according to plan. Our Alberta liquor business continued to...